PMV Investors

PMV Pharma is developing first-in-class p53 regulators for the treatment of cancer. PMV Pharma combines unique biological understanding with pharmaceutical development focus.


Founded Date: 2013
Technology: DeepTech, SpaceTech
Investor Type: Government Office, Venture Capital
Employee Number: 51-100
Headquarters: Brussels, Brussels Hoofdstedelijk Gewest, Belgium
Estimated Revenue: $10M to $50M
Investment Stage: Early Stage Venture
Number Of Exists: 13
Industry: Asset Management, Business Development, Enterprise Software, Financial Services, Venture Capital